Ann Pope

Radiofrequency-induced Thermo-chemotherapy Effect Versus a Second Course of Bacillus Calmette-Guérin or Institutional Standard in Patients with Recurrence of Non–muscle-invasive Bladder Cancer Following Induction or Maintenance Bacillus Calmette-Guérin Therapy (HYMN): A Phase III, Open-label, Randomised Controlled Trial

Wei Shen Tan, Anesh Panchal, Laura Buckley et al. · European Urology · 2018 · 137 citations · Full text

Urological Research, Urology, Surgical Oncology +8

SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease

Eleanor Barnes, Carl S. Goodyear, Michelle Willicombe et al. · Nature Medicine · 2023 · 124 citations · Full text

Clinical Outcomes and Survival Following Treatment of Metastatic Castrate-Refractory Prostate Cancer With Docetaxel Alone or With Strontium-89, Zoledronic Acid, or Both

Nicholas D. James, Sarah Pirrie, Ann Pope et al. · JAMA Oncology · 2016 · 87 citations · Full text

Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study

Richard T. Bryan, Wenyu Liu, Sarah Pirrie et al. · European Urology · 2021 · 63 citations

Urogenital Radiology, Urology, Medical Imaging +9

TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancer

Nicholas D. James, Sarah Pirrie, Ann Pope et al. · Health Technology Assessment · 2016 · 54 citations · Full text